Diabetic Foot Ulcers (DFU)NCT06977048
Effects of an Animated Mobile Application on Diabetic Foot Ulcer Management
A study testing Mobile Application-Based Educational Program in people with Diabetic Foot Ulcers (DFU), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This study was designed to evaluate the effect of education delivered through an animation-based mobile application on the knowledge level, self-efficacy, wound size, and metabolic parameters of individuals with diabetic foot ulcers. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetic Foot Ulcers (DFU)
- What is being tested?
- Mobile Application-Based Educational Program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 74 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Apr 2025to 25 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Having a diagnosis of diabetic foot ulcer, having stage 1-2 diabetic foot ulcer according to Wagner classification system, being between the ages of 18-65, being literate, having and using a mobile phone with IOS and ANDROID operating system, volunteering to participate in the study
Who cannot join
- Users who want to withdraw from the research, the patient's exitus during the research process, users who do not log in to the mobile application once a week during the implementation process of the research (twelve weeks) will be excluded from the research.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gülhane Training and Research Hospital, University of Health Sciences, Turkey
Ankara, Keçiören, 06300
About this study
Official title: The Effect of Education Provided Through an Animation-based Mobile Application on Disease Knowledge, Self-efficacy, Wound Size, and Metabolic Parameters in Patients With Diabetic Foot Ulcers: A Randomized Controlled Trial
This study was designed to evaluate the effect of education delivered through an animation-based mobile application on the knowledge level, self-efficacy, wound size, and metabolic parameters of individuals with diabetic foot ulcers.
Read the detailed description
Diabetic foot is one of the most serious complications of diabetes, negatively affecting not only patients but also caregivers, healthcare professionals, and the broader society, both medically and economically. Peripheral neuropathy, peripheral arterial disease, microvascular and macrovascular alterations, impaired glycemic regulation, recurrent trauma, and inadequate foot care can lead to the development of diabetic foot ulcers (DFUs), which may progress to osteomyelitis. Each year, approximately 18.6 million people worldwide are affected by diabetic foot ulcers. The five-year mortality rate among these individuals is around 30%, and it exceeds 70% in those with a history of major amputation. Primary treatment approaches for DFUs include surgical debridement, offloading, treatment of peripheral arterial disease, and infection management. Additionally, therapies such as hyperbaric oxygen, wound dressings, negative pressure wound therapy, and topical oxygen are also employed in the management of diabetic foot ulcers. Compared to amputations due to other causes, a significant proportion of amputations resulting from DFUs are preventable. For this reason, education on diabetes and foot care has been shown to prevent ulcer formation and subsequently reduce amputation rates and associated morbidity.
Individuals with diabetes need to possess an adequate level of self-efficacy in order to effectively manage lifelong treatment, care, and lifestyle changes. Self-efficacy is defined as a cognitive process through which individuals believe they can influence future outcomes via environmental and social factors and thereby learn new behaviors. It is known that individuals with high self-efficacy are more actively involved in their own care and experience the chronic disease process more successfully. In diabetes management, perceived self-efficacy is considered crucial by researchers and clinicians, as it is associated with adopting a healthy lifestyle, adhering to medication and treatment regimens, and managing stress. Assessing and promoting patients' self-efficacy is a valuable tool in healthcare settings as it enhances motivation for self-care. Supporting patients in this regard may increase life expectancy and help regulate health behaviors. In a study by Bahador et al., a three-month education program for patients with diabetic foot ulcers significantly improved self-efficacy, foot ulcer care rates, and reduced re-ulceration and complication rates. Similarly, Ayaz, Dinçer, and Oğuz (2020) reviewed 26 systematic studies and 8 meta-analyses on the effects of foot care education in diabetic patients and found that such education improved patients' knowledge and behaviors. The authors emphasized the need for long-term educational interventions.
Recent advances in technology and healthcare worldwide have fostered the integration of these two fields and brought mobile health applications to the forefront. Mobile health applications are software tools used via mobile devices such as smartphones or tablets, and they offer advantages over traditional methods. These applications are employed in the management of various chronic diseases including chronic obstructive pulmonary disease (COPD), depression, dementia, and diabetes, particularly for medication adherence, rehabilitation, symptom control, and tracking medical records. In a study by Marquen et al., a mobile application combined with nursing consultation improved foot self-care among individuals with type 2 diabetes. Similarly, Kilic and Karadag developed a Mobile Diabetic Foot Self-Care System for patients with diabetes mellitus, which enhanced patients' knowledge, behaviors, and self-efficacy scores. The use of mobile applications plays a significant role in advancing mobile health technologies, and it is important that such applications are supported by daily messages, videos, and animations.
Animation is a form of educational material that uses visual simulations to present theoretical knowledge in a more accessible format. Through animation videos, key points of a topic can be highlighted to improve patient understanding, allow repeated viewing of the material, and enhance knowledge levels. In a study by Alyami et al., visual animations shown to patients with type 2 diabetes, their caregivers, and healthcare professionals were found to improve patients' perceptions and enhance the effectiveness of diabetes education. Likewise, Maisrikrod et al. developed an animated educational tool aimed at increasing community awareness in tropical regions where melioidosis and diabetes are prevalent. They concluded that such tools can serve as low-cost, adaptable health education materials.
- Conditions
- Diabetic Foot Ulcers (DFU)
- Being tested
- Mobile Application-Based Educational Program, Standard care
- Keywords
- diabetic foot, animation
- Medical subject headings
- Diabetic Foot
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile Application-Based Educational ProgramOther
Week 0:
Participants are informed about the study and trained in the use of the mobile application.
The mobile app is installed on their smartphones.
Educational animation videos and modules are watched with the researcher in a predefined order.
Questions about animations are answered.
Videos are downloaded to the participant's phone.
DFU photographs are recorded.
Weeks 1-12:
Participants are instructed to use the app regularly between weeks 5-12.
Video watching days and durations are logged using a tracking form.
Weekly push notifications remind participants to use the app.
Weekly phone calls are made to assess engagement using a structured checklist.
DFU photographs are taken at weeks 8 and 12.
At week 12, data are collected in person, including:
DFU size (length × width) with disposable paper ruler
Metabolic parameters from blood tests
Wagner-Meggitt classification
Re-ulceration assessment
Standard careOther
Participants provide consent and receive baseline information.
DFU photographs are taken at baseline, week 8, and week 12.
At week 12, the same outcome measures as the intervention group are collected.
After the study ends, participants are provided with access to the mobile application.
| Study group | Role | What they receive |
|---|---|---|
| Experimental - Mobile Application-Based Education Group (Intervention Group) | Other | Participants receive an educational intervention via a mobile application with animation-based videos and modules on diabetic foot ulcer (DFU) care. The intervention spans 12 weeks and includes initial training and weekly follow-ups. Receives: Other: Mobile Application-Based Educational Program |
| No Intervention - Control Group | Other | Participants in this group receive no educational intervention and continue their usual care. Receives: Other: Standard care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Diabetic Foot Ulcer Size (cm²)
This outcome measures the change in the surface area (cm²) of the diabetic foot ulcer from baseline (Week 0) to the end of the intervention (Week 12). The wound size is calculated using the formula length × width (cm × cm).
Measured: aseline (Week 0) Follow-up (Week 12) (Optional intermediate check at Week 8)
The Diabetic Foot Care Self-Efficacy Scale (DFCSES)
The Diabetic Foot Care Self-Efficacy Scale (DFCSES), originally developed by Quarles (2005) and adapted into Turkish by Kır Biçer (2011), will be used to assess participants' self-efficacy regarding diabetic foot care. The scale consists of 9 items rated on a scale from 0 (not confident at all) to 10 (completely confident), with total scores ranging from 0 to 90. Higher scores reflect greater self-efficacy in diabetic foot care. The change in total score from baseline to 12 weeks post-intervention will be evaluated.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in Diabetic Foot Knowledge Score
Knowledge of diabetic foot care will be measured using a 5-item subscale from the Diabetes Knowledge Questionnaire-24 (DKQ-24), originally developed by Garcia et al. and adapted into Turkish by Biçer. Each item is answered as "Yes," "No," or "I don't know." Total scores range from 0 to 5, with higher scores reflecting greater knowledge of diabetic foot care. The change in score from baseline to 12 weeks post-intervention will be assessed.
Measured: Baseline (Week 0) Follow-up (Week 12)
Secondary outcomes (7)
Change in HbA1c (%)
HbA1c levels will be measured as part of routine laboratory testing. The change in HbA1c (%) from baseline to 12 weeks after the intervention will be evaluated.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in Fasting Blood Glucose (mg/dL)
Fasting blood glucose (mg/dL) levels will be obtained from routine clinical tests. The change between baseline and 12 weeks post-intervention will be assessed.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in Triglycerides (mg/dL)
Serum triglyceride levels (mg/dL) will be recorded from routine lab results. The change from baseline to 12 weeks will be analyzed.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in HDL Cholesterol (mg/dL)
HDL levels (mg/dL) will be obtained from standard lab testing. The difference between pre- and post-intervention values will be evaluated.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in LDL Cholesterol (mg/dL)
LDL cholesterol levels (mg/dL) will be retrieved from routine blood tests. Change from baseline to follow-up will be measured.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in Total Cholesterol (mg/dL)
Total cholesterol levels (mg/dL) will be taken from regular lab reports. Change from baseline to 12 weeks will be analyzed.
Measured: Baseline (Week 0) Follow-up (Week 12)
Change in Body Mass Index (BMI, kg/m²)
BMI will be calculated from measured height and weight. The change in BMI (kg/m²) from baseline to 12 weeks post-intervention will be recorded.
Measured: Baseline (Week 0) Follow-up (Week 12)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 May 2025
- Study start30 Apr 2025
- Primary completion1 Dec 2025 (estimated)
- Study completion25 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetic Foot Ulcers (DFU)Studies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Patients will be divided into intervention and control groups by simple randomisation.
- Masking
- None (open label)
- Enrolment
- 74 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehtap Günel, Saglik Bilimleri Universitesi
- Investigators
- Ayla D Demirtaş, Principal investigator, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06977048
- Sponsor's protocol ID
- SBU-H-MG-06
- Status last verified
- Apr 2025
- First submitted
- 1 May 2025
- Last updated
- 16 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The individual participant data (IPD) will not be shared due to ethical concerns and institutional policy restrictions. The collected data include sensitive health information that cannot be anonymized adequately to protect participant privacy.
Study at a glance
From the registry record, last updated by the sponsor on 16 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Education Provided Through an Animation-based Mobile Application on Disease Knowledge, Self-efficacy, Wound Size, and Metabolic Parameters in Patients With Diabetic Foot Ulcers: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06977048
- Acronym / sponsor ID
- SBU-H-MG-06
- Conditions
- Diabetic Foot Ulcers (DFU)
- Keywords
- diabetic foot, animation
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 74 participants (estimated)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 30 Apr 2025 (actual)
- Primary completion
- 1 Dec 2025 (estimated)
- Study completion
- 25 Dec 2025 (estimated)
- First posted
- 16 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was designed to evaluate the effect of education delivered through an animation-based mobile application on the knowledge level, self-efficacy, wound size, and metabolic parameters of individuals with diabetic foot ulcers.
Detailed description
Diabetic foot is one of the most serious complications of diabetes, negatively affecting not only patients but also caregivers, healthcare professionals, and the broader society, both medically and economically. Peripheral neuropathy, peripheral arterial disease, microvascular and macrovascular alterations, impaired glycemic regulation, recurrent trauma, and inadequate foot care can lead to the development of diabetic foot ulcers (DFUs), which may progress to osteomyelitis. Each year, approximately 18.6 million people worldwide are affected by diabetic foot ulcers. The five-year mortality rate among these individuals is around 30%, and it exceeds 70% in those with a history of major amputation. Primary treatment approaches for DFUs include surgical debridement, offloading, treatment of peripheral arterial disease, and infection management. Additionally, therapies such as hyperbaric oxygen, wound dressings, negative pressure wound therapy, and topical oxygen are also employed in the management of diabetic foot ulcers. Compared to amputations due to other causes, a significant proportion of amputations resulting from DFUs are preventable. For this reason, education on diabetes and foot care has been shown to prevent ulcer formation and subsequently reduce amputation rates and associated morbidity.
Individuals with diabetes need to possess an adequate level of self-efficacy in order to effectively manage lifelong treatment, care, and lifestyle changes. Self-efficacy is defined as a cognitive process through which individuals believe they can influence future outcomes via environmental and social factors and thereby learn new behaviors. It is known that individuals with high self-efficacy are more actively involved in their own care and experience the chronic disease process more successfully. In diabetes management, perceived self-efficacy is considered crucial by researchers and clinicians, as it is associated with adopting a healthy lifestyle, adhering to medication and treatment regimens, and managing stress. Assessing and promoting patients' self-efficacy is a valuable tool in healthcare settings as it enhances motivation for self-care. Supporting patients in this regard may increase life expectancy and help regulate health behaviors. In a study by Bahador et al., a three-month education program for patients with diabetic foot ulcers significantly improved self-efficacy, foot ulcer care rates, and reduced re-ulceration and complication rates. Similarly, Ayaz, Dinçer, and Oğuz (2020) reviewed 26 systematic studies and 8 meta-analyses on the effects of foot care education in diabetic patients and found that such education improved patients' knowledge and behaviors. The authors emphasized the need for long-term educational interventions.
Recent advances in technology and healthcare worldwide have fostered the integration of these two fields and brought mobile health applications to the forefront. Mobile health applications are software tools used via mobile devices such as smartphones or tablets, and they offer advantages over traditional methods. These applications are employed in the management of various chronic diseases including chronic obstructive pulmonary disease (COPD), depression, dementia, and diabetes, particularly for medication adherence, rehabilitation, symptom control, and tracking medical records. In a study by Marquen et al., a mobile application combined with nursing consultation improved foot self-care among individuals with type 2 diabetes. Similarly, Kilic and Karadag developed a Mobile Diabetic Foot Self-Care System for patients with diabetes mellitus, which enhanced patients' knowledge, behaviors, and self-efficacy scores. The use of mobile applications plays a significant role in advancing mobile health technologies, and it is important that such applications are supported by daily messages, videos, and animations.
Animation is a form of educational material that uses visual simulations to present theoretical knowledge in a more accessible format. Through animation videos, key points of a topic can be highlighted to improve patient understanding, allow repeated viewing of the material, and enhance knowledge levels. In a study by Alyami et al., visual animations shown to patients with type 2 diabetes, their caregivers, and healthcare professionals were found to improve patients' perceptions and enhance the effectiveness of diabetes education. Likewise, Maisrikrod et al. developed an animated educational tool aimed at increasing community awareness in tropical regions where melioidosis and diabetes are prevalent. They concluded that such tools can serve as low-cost, adaptable health education materials.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Patients will be divided into intervention and control groups by simple randomisation.
| Arm | Type | Receives |
|---|---|---|
| Experimental - Mobile Application-Based Education Group (Intervention Group) | Other | Other: Mobile Application-Based Educational ProgramParticipants receive an educational intervention via a mobile application with animation-based videos and modules on diabetic foot ulcer (DFU) care. The intervention spans 12 weeks and includes initial training and weekly follow-ups. |
| No Intervention - Control Group | Other | Other: Standard careParticipants in this group receive no educational intervention and continue their usual care. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Having a diagnosis of diabetic foot ulcer, having stage 1-2 diabetic foot ulcer according to Wagner classification system, being between the ages of 18-65, being literate, having and using a mobile phone with IOS and ANDROID operating system, volunteering to participate in the study
Key exclusion criteria (1 listed)
- Users who want to withdraw from the research, the patient's exitus during the research process, users who do not log in to the mobile application once a week during the implementation process of the research (twelve weeks) will be excluded from the research.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile Application-Based Educational ProgramWeek 0: Participants are informed about the study and trained in the use of the mobile application. The mobile app is installed on their smartphones. Educational animation videos and modules are watched with the researcher in a predefined order. Questions about animations are answered. Videos are downloaded to the participant's phone. DFU photographs are recorded. Weeks 1-12: Participants are instructed to use the app regularly between weeks 5-12. Video watching days and durations are logged using a tracking form. Weekly push notifications remind participants to use the app. Weekly phone calls are made to assess engagement using a structured checklist. DFU photographs are taken at weeks 8 and 12. At week 12, data are collected in person, including: DFU size (length × width) with disposable paper ruler Metabolic parameters from blood tests Wagner-Meggitt classification Re-ulceration assessment | Other | Experimental - Mobile Application-Based Education Group (Intervention Group) |
| Standard careParticipants provide consent and receive baseline information. DFU photographs are taken at baseline, week 8, and week 12. At week 12, the same outcome measures as the intervention group are collected. After the study ends, participants are provided with access to the mobile application. | Other | No Intervention - Control Group |
Primary outcome
Change in Diabetic Foot Ulcer Size (cm²)
Time frame: aseline (Week 0) Follow-up (Week 12) (Optional intermediate check at Week 8)
This outcome measures the change in the surface area (cm²) of the diabetic foot ulcer from baseline (Week 0) to the end of the intervention (Week 12). The wound size is calculated using the formula length × width (cm × cm).
The Diabetic Foot Care Self-Efficacy Scale (DFCSES)
Time frame: Baseline (Week 0) Follow-up (Week 12)
The Diabetic Foot Care Self-Efficacy Scale (DFCSES), originally developed by Quarles (2005) and adapted into Turkish by Kır Biçer (2011), will be used to assess participants' self-efficacy regarding diabetic foot care. The scale consists of 9 items rated on a scale from 0 (not confident at all) to 10 (completely confident), with total scores ranging from 0 to 90. Higher scores reflect greater self-efficacy in diabetic foot care. The change in total score from baseline to 12 weeks post-intervention will be evaluated.
Change in Diabetic Foot Knowledge Score
Time frame: Baseline (Week 0) Follow-up (Week 12)
Knowledge of diabetic foot care will be measured using a 5-item subscale from the Diabetes Knowledge Questionnaire-24 (DKQ-24), originally developed by Garcia et al. and adapted into Turkish by Biçer. Each item is answered as "Yes," "No," or "I don't know." Total scores range from 0 to 5, with higher scores reflecting greater knowledge of diabetic foot care. The change in score from baseline to 12 weeks post-intervention will be assessed.
7 secondary outcomes
Change in HbA1c (%)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in Fasting Blood Glucose (mg/dL)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in Triglycerides (mg/dL)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in HDL Cholesterol (mg/dL)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in LDL Cholesterol (mg/dL)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in Total Cholesterol (mg/dL)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Change in Body Mass Index (BMI, kg/m²)
Time frame: Baseline (Week 0) Follow-up (Week 12)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 May 2025.
- Individual participant dataSharing planned: No. The individual participant data (IPD) will not be shared due to ethical concerns and institutional policy restrictions. The collected data include sensitive health information that cannot be anonymized adequately to protect participant privacy.
Related trials for Diabetic Foot Ulcers (DFU)
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Recruiting
DiaFootCare to Promote Self-Care of Diabetic Foot Ulcers in Oman
Diabetic Foot Ulcer (DFU), Diabetes Mellitus
Recruiting
Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic Polyneuropathy in Type 2 Diabetic Patients and Its Effect on Wound Healing
Diabetic Foot Ulcer (DFU), Diabetic Symmetrical Polyneuropathy
Active, not recruiting
Remote Temperature and Visual Monitoring To Help Manage Diabetic Foot Ulcers
Diabetic Foot Ulcer (DFU)
Recruiting
Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
Diabetic Foot Ulcer, Foot Ulcer Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ayla D Demirtaş principal investigator
Saglik Bilimleri Universitesi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mobile Application-Based Educational Program in people with Diabetic Foot Ulcers (DFU), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Diabetic Foot Ulcer Size (cm²) (time frame: aseline (Week 0) Follow-up (Week 12) (Optional intermediate check at Week 8)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025; AzTrials last refreshed its copy on 7 Nov 2026.